On 1 July 2026, the UK Health Security Agency and NHS England announced that, starting 1 September 2026, the NHS respiratory syncytial virus (RSV) vaccination programme will extend eligibility to adults aged 65 to 74 who belong to certain clinical at‑risk groups. The announcement, published as a formal letter and accompanied by an annex, provides detailed guidance and resources for healthcare professionals. The expansion is part of an effort to improve protection for older adults against RSV, a serious respiratory infection. The documents outline which clinical conditions qualify for the new eligibility and describe how the programme will be implemented across the NHS.
© Crown copyright, 2024, GOV.UK.
Summary adapted from content licensed under the Open Government Licence v3.0.
For details, see https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/.
Original source: https://www.gov.uk/
Made by AI. If you spot anything of concern write us at contact@cybach.com. We’ll promptly correct irregularities.